Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DMIIDrugs Made In America Acquisition II Corp.

Nasdaq · CIK 0002040475
Filer category<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts90

Identity from submissions API

NameDrugs Made In America Acquisition II Corp.
CIK0002040475
TickersDMII, DMIIR, DMIIU
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone954-870-3104
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
420 LEXINGTON AVENUE
SUITE 1402
NEW YORK
NY
10170
NY
Mailing address
420 LEXINGTON AVENUE
SUITE 1402
NEW YORK
NY
10170
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

48 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 8-K FORM 8-K 2.03,8.01,9.01 0001477932-26-007137 001-42863 261568681 34 223086 1 1
2026-11-16 10-Q FORM 10-Q 0001477932-26-007044 001-42863 261560557 34 3994789 1 1
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001072613-26-000875 005-95248 261552238 34 7715
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090017 001-42863 261281259 34 3809711 1 1
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056651 001-42863 26979259 34 3586973 1 1
2026-04-28 8-K CURRENT REPORT 1.01,9.01 0001213900-26-048687 001-42863 26909426 34 291565 1 1
2026-04-15 10-K ANNUAL REPORT 0001213900-26-044055 001-42863 26864250 34 4843522 1 1
2026-04-03 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-26-039986 001-42863 26838602 34 300895 1 1
2026-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-038498 001-42863 26828103 34 22811
2026-03-17 8-K CURRENT REPORT 1.01,2.03,8.01,9.01 0001213900-26-029050 001-42863 26761627 34 338297 1 1
2026-03-06 8-K FORM 8-K 8.01 0001213900-26-024763 001-42863 26732041 34 250205 1 1
2026-03-06 8-K CURRENT REPORT 5.02 0001213900-26-024387 001-42863 26728980 34 258661 1 1
2025-11-18 10-Q QUARTERLY REPORT 0001213900-25-112095 001-42863 251494629 34 3485993 1 1
2025-11-18 8-K CURRENT REPORT 5.02 0001213900-25-111706 001-42863 251492594 34 268426 1 1
2025-11-17 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-111209 001-42863 251489125 34 23057
2025-10-17 4 xslF345X05/ownership.xml 0001213900-25-099838 4828
2025-10-02 8-K CURRENT REPORT 8.01,9.01 0001213900-25-095513 001-42863 251370643 34 133917
2025-10-02 4 xslF345X05/ownership.xml 0001213900-25-095291 4845
2025-10-02 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-094944 005-95248 251366972 34 28024
2025-10-01 4 xslF345X05/ownership.xml 0001213900-25-094676 4891
2025-10-01 4 xslF345X05/ownership.xml 0001213900-25-094436 11853
2025-10-01 4 xslF345X05/ownership.xml 0001213900-25-094430 11136
2025-10-01 4 xslF345X05/ownership.xml 0001213900-25-094427 4844
2025-09-29 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,8.01,9.01 0001213900-25-093224 001-42863 251357469 34 1106951
2025-09-25 3 xslF345X02/ownership.xml 0001213900-25-091842 3841
2025-09-25 424B4 PROSPECTUS SUPPLEMENT 0001213900-25-091724 333-288791 251344675 33 4290305
2025-09-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003076 333-288791 251340135 33 1757
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091255 3005
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091254 4261
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091253 2959
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091251 2958
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091250 2942
2025-09-24 CERT DMII_8A_Cert_2040475.pdf 0001354457-25-000943 001-42863 251339198 34 122255
2025-09-24 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-091080 001-42863 251337961 34 14778
2025-09-22 CORRESP filename1.htm 0001213900-25-089929 8288
2025-09-22 CORRESP filename1.htm 0001213900-25-089923 10995
2025-09-16 CORRESP filename1.htm 0001213900-25-088056 16020
2025-09-16 S-1/A REGISTRATION STATEMENT 0001213900-25-088044 333-288791 251316491 33 7528352 1 1
2025-09-15 UPLOAD filename1.pdf 0000000000-25-009970 377-07803 44818
2025-09-15 S-1/A REGISTRATION STATEMENT 0001213900-25-087444 333-288791 251313328 33 7897611 1 1
2025-09-05 S-1/A REGISTRATION STATEMENT 0001213900-25-085167 333-288791 251297599 33 7903084 1 1
2025-07-21 S-1 REGISTRATION STATEMENT 0001213900-25-065837 333-288791 251135567 33 8972100 1 1
2025-07-18 CORRESP filename1.htm 0001213900-25-065839 22329
2025-05-02 UPLOAD filename1.pdf 0000000000-25-004707 377-07803 42878
2025-04-25 DRSLTR filename1.htm 0001213900-25-035423 39875
2025-04-25 DRS/A filename1.htm 0001213900-25-035420 377-07803 25872167 33 4175472
2025-04-14 UPLOAD filename1.pdf 0000000000-25-003925 377-07803 52798
2025-03-19 DRS filename1.htm 0001213900-25-025159 377-07803 25753757 33 4043293

Latest XBRL company facts

One latest value per concept from companyfacts (90 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 63.70M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 78,504 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1,752 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 10.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 782,113 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 782,113 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap Assets Assets USD 518.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AssetsCurrent Assets, Current USD 139,657 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 518.58M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap AssetsNoncurrent Assets, Noncurrent USD 518.58M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap Cash Cash USD 174,974 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 174,974 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 118,232 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 118,009 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 220.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 13.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 13.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,369 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 17.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 78,449 2024-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 553,748 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 321,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -43,957 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -45,113 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 88,343 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -4,389 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 13.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap Liabilities Liabilities USD 18.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 518.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 553,748 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112095
us-gaap LiabilitiesCurrent Liabilities, Current USD 643,418 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 17.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -331,991 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 13.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 8.98M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap NotesPayableCurrent Notes Payable, Current USD 450,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056651
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 77,799 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap OperatingExpenses Operating Expenses USD 321,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -321,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap OtherBorrowings Other Borrowings USD 325,000 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112095
us-gaap OtherExpenses Other Expenses USD 18,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 13.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap OtherReceivableAfterAllowanceForCreditLossNoncurrent OtherReceivableAfterAllowanceForCreditLossNoncurrent USD 782,113 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 21,425 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 500.00M 2025-01-01 2025-12-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 10.36M 2025-01-01 2025-12-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 500.00M 2025-09-26 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 450,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD -30,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 325,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -18.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap ShortTermBorrowings Short-term Debt USD 450,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -18.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 12.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 638,354 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044055
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 4.51M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090017
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 518.58M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.37 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap TimeDepositsAtOrAboveFDICInsuranceLimit Time Deposits, at or Above FDIC Insurance Limit USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007044
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2024-12-31 2025 Q3 10-Q 2025-11-18 0001213900-25-112095
us-gaap UnsecuredDebt Unsecured Debt USD 150,000 2026-03-11 2026 Q2 10-Q 2026-08-14 0001213900-26-090017

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →